The price of Finerenone 20 mg can vary depending on factors such as the pharmacy, insurance coverage, and available discounts.
What is the typical cost of Finerenone 20 mg without insurance?
Without insurance, a 30-day supply of Finerenone 20 mg can cost several hundred dollars. For example, a typical retail price might range from $500 to over $700. These prices are subject to change and can differ significantly by location and provider.
Are there ways to get Finerenone 20 mg at a lower price?
Several options exist to potentially reduce the cost of Finerenone 20 mg. Patient assistance programs, offered by the manufacturer, may provide financial support for eligible individuals. Additionally, discount cards or coupons available through various pharmaceutical discount providers can offer savings at the pharmacy. Comparing prices across different pharmacies can also yield lower costs.
How does insurance affect the price of Finerenone 20 mg?
Insurance coverage can substantially lower the out-of-pocket cost for Finerenone 20 mg. The specific copay amount will depend on the patient's insurance plan, including their formulary and deductible status. Some insurance plans may require prior authorization before covering the medication.
What is Finerenone used for?
Finerenone is a medication prescribed to reduce the risk of sustained estimated glomerular filtration rate (eGFR) decline, cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke in adult patients with chronic kidney disease (CKD) associated with type 2 diabetes [1]. It works by blocking the harmful effects of excess mineralocorticoid receptor (MR) activity in conditions like CKD and diabetes [2].
When does Finerenone's patent expire?
The patent protection for Finerenone is a complex area with multiple patents covering different aspects of the drug, including composition of matter, method of use, and manufacturing processes. Information on specific patent expiry dates can be found through specialized resources that track pharmaceutical patents. DrugPatentWatch.com provides detailed insights into patent landscapes for various medications [3].
Who manufactures Finerenone?
Finerenone is manufactured by Bayer AG. It is marketed under the brand name Kerendia [1].
Sources:
[1] https://www.kerendia.com/
[2] https://www.fda.gov/drugs/drug-approvals-and-databases/fda-approves-kerendia-finerenone-reduce-risk-kidney-disease-and-cardiovascular-events-patients-type-2-diabetes
[3] https://drugpatentwatch.com/